Vanda Pharmaceuticals | Resultado Líquido





Resultado Líquido Alterar Data
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
AstraZeneca USD 2.53B 83M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -370.02M 48.34M 2025-09
J&J USD 5.12B 36M 2025-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -200M 625M 2025-09
Novartis USD 3.93B 113M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Veracyte USD 19.14M 20.12M 2025-09


Vanda Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.